Matrix metalloproteinases (MMPs) produced by resident and inflammatory cells in response to periodontopathogens play a major role in periodontal tissue destruction. Our aim was to investigate the effects of A-type cranberry proanthocyanidins (AC-PACs) on: (i) the production of various MMPs by human monocyte-derived macrophages stimulated with Aggregatibacter actinomycetemcomitans lipopolysaccharide (LPS), and (ii) the catalytic activity of recombinant MMP-1 and MMP-9. The effects of AC-PACs on the expression of 5 protein kinases and the activity of nuclear factor-kappa B (NF-κB) p65 in macrophages stimulated with LPS were also monitored. Our results indicated that AC-PACs inhibited the production of MMPs in a concentration-dependent manner. Furthermore, the catalytic activity of MMP-1 and MMP-9 was also inhibited. The inhibition of MMP production was associated with reduced phosphorylation of key intracellular kinases and the inhibition of NF-κB p65 activity. AC-PACs thus show potential for the development of novel host-modulating strategies to inhibit MMP-mediated tissue destruction during periodontitis.
Get full access to this article
View all access options for this article.
References
1.
Birkedal-Hansen H -1993-. Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res28-6 Pt 2-:500–510.
2.
Blavier L, Delaisse JM -1995-. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci108-Pt 12-:3649–3659.
3.
Bodet C, Chandad F, Grenier D -2006a-. Anti-inflammatory activity of a high-molecular-weight cranberry fraction on macrophages stimulated by lipopolysaccharides from periodontopathogens. J Dent Res85: 235–239.
4.
Bodet C, Piche M, Chandad F, Grenier D -2006b-. Inhibition of periodontopathogen-derived proteolytic enzymes by a high-molecular-weight fraction isolated from cranberry. J Antimicrob Chemother57: 685–690.
5.
Bodet C, Chandad F, Grenier D -2007-. Cranberry components inhibit interleukin-6, interleukin-8, and prostaglandin E production by lipopolysaccharide-activated gingival fibroblasts. Eur J Oral Sci115:64–70.
6.
Caton JG, Ciancio SG, Blieden TM, Bradshaw M, Crout RJ, Hefti AF, et al. -2000-. Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol71:521–532.
7.
Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T -2003-. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem253:269–285.
8.
Chase AJ, Bond M, Crook MF, Newby AC -2002-. Role of nuclear factor-kappa B activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler Thromb Vasc Biol22:765–771.
9.
Duarte S, Gregoire S, Singh AP, Vorsa N, Schaich K, Bowen WH, et al. -2006-. Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms. FEMS Microbiol Lett257:50–56.
10.
Emingil G, Tervahartiala T, Mantyla P, Maatta M, Sorsa T, Atilla G -2006-. Gingival crevicular fluid matrix metalloproteinase -MMP--7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease. J Periodontol77:2040–2050.
11.
Ferguson PJ, Kurowska E, Freeman DJ, Chambers AF, Koropatnick DJ -2004-. A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr134:1529–1535.
12.
Foo LY, Lu Y, Howell AB, Vorsa N -2000-. The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro. Phytochemistry54:173–181.
13.
Gu L, Kelm MA, Hammerstone JF, Beecher G, Holden J, Haytowitz D, et al. -2003-. Screening of foods containing proanthocyanidins and their structural characterization using LC-MS/MS and thiolytic degradation. J Agric Food Chem51:7513–7521.
14.
Hannas AR, Pereira JC, Granjeiro JM, Tjäderhane L -2007-. The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand65 :1–13.
15.
Hernandez M, Valenzuela MA, Lopez-Otín C, Alvarez J, Lopez JM, Vernal R, et al. -2006-. Matrix metalloproteinase-13 is highly expressed in destructive periodontal disease activity. J Periodontol77 :1863–1870.
Kivela-Rajamaki M, Maisi P, Srinivas R, Tervahartiala T, Teronen O, Husa V, et al. -2003-. Levels and molecular forms of MMP-7 -matrilysin-1- and MMP-8 -collagenase-2- in diseased human peri-implant sulcular fluid. J Periodontal Res38:583–590.
18.
Kubota T, Nomura T, Takahashi T, Hara K -1996-. Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue. Arch Oral Biol41 :253–262.
19.
Labrecque J, Bodet C, Chandad F, Grenier D -2006-. Effects of a high- molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis. J Antimicrob Chemother58: 439–443.
20.
Lim H, Kim HP -2007-. Inhibition of mammalian collagenase, matrix metalloproteinase-1, by naturally-occurring flavonoids. Planta Med73 :1267–1274.
Minden A, Karin M -1997-. Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta1333:F85–F104.
23.
Neto CC, Krueger GC, Lamoureaux LT, Kondo M, Vaisberg JA, Hurta RAR, et al. -2006-. MALDI-TOF MS characterization of proanthocyanidins from cranberry fruit -Vaccinium macrocarpon- that inhibit tumor cell growth and matrix metalloproteinase expression in vitro. J Sci Food Agri86:18–25.
24.
Novak MJ, Johns LP, Miller RC, Bradshaw MH -2002-. Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis. J Periodontol73:762–769.
25.
Ogata Y, Enghild JJ, Nagase H -1992-. Matrix metalloproteinase 3 -strome-lysin- activates the precursor for the human matrix metalloproteinase 9. J Biol Chem267:3581–3584.
26.
Rai B, Kharb S, Jain R, Anand SC -2008-. Biomarkers of periodontitis in oral fluids. J Oral Sci50:53–56.
27.
Ramamurthy NS, Xu JW, Bird J, Baxter A, Bhogal R, Wills R, et al. -2002-. Inhibition of alveolar bone loss by matrix metalloproteinase inhibitors in experimental periodontal disease. J Periodontal Res37:1–7.
28.
Raz R, Chazan B, Dan M -2004-. Cranberry juice and urinary tract infection. Clin Infect Dis38:1413–1419.
29.
Smith PC, Munoz VC, Collados L, Oyarzun AD -2004-. In situ detection of matrix metalloproteinase-9 -MMP-9- in gingival epithelium in human periodontal disease. J Periodontal Res39:87–92.
30.
Soell M, Elkaim R, Tenenbaum H -2002-. Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients. J Dent Res81:174–178.
31.
Sorsa T, Suomalainen K, Uitto VJ -1990-. The role of gingival crevicular fluid and salivary interstitial collagenases in human periodontal diseases. Arch Oral Biol35-Suppl-:193S–196S.
32.
Sorsa T, Tjäderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al. -2006-. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med38:306–321.
33.
Teng YT, Sodek J, McCulloch CA -1992-. Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects. J Periodontal Res27:544–552.
34.
Wilson CL, Matrisian LM -1996-. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol28 :123–136.
35.
Woessner JF Jr -1991-. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J5:2145–2154.
